All In Biotech

Free tool

FAERS Monitor: Ketalar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 016812 or its brand name (Ketalar, Ketamine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,133

Serious

3,592

70% of reports

Hospitalization

1,603

Death reported

562

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • infusion site pain797
  • drug ineffective564
  • nausea545
  • off label use539
  • infusion site erythema501
  • infusion site swelling347
  • headache342
  • diarrhoea317
  • drug abuse315
  • dyspnoea313
  • hyperhidrosis238
  • fatigue237
  • sedation232
  • infusion site haemorrhage227
  • vomiting225

Reports by year received

View as table
YearReports
200420
200520
20065
200735
200828
200959
201094
201161
201283
201384
2014104
201594
2016114
201784
201864
2019143
2020114
2021194
2022240
2023563
20241,079
20251,106
2026744

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,026 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion site haemorrhageSignal227303.6266.163,475
infusion site painSignal797270.0252.7200,301
infusion site erythemaSignal501258.8237.5120,833
infusion site swellingSignal347239.1215.377,544
sedationSignal23236.632.37,940
drug abuseSignal31515.614.04,278
hyperhidrosisSignal2387.66.71,359
nauseaSignal5452.82.6664
off label useSignal5392.52.3515
dyspnoeaSignal3132.32.0226
headacheSignal3422.22.0239
diarrhoeaSignal3172.01.8166
vomiting2252.01.7107
drug ineffective5641.81.6194
fatigue2371.21.112

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.